The present invention relates to a stable solid pharmaceutical composition comprising or consisting of bosentan or a pharmaceutically acceptable salt thereof, a first diluent or filler which is a cellulose derivative and a second diluent or filler which is different from the first diluent as well as a process for manufacturing the inventive pharmaceutical composition.